Faruqi and Faruqui, LLP Logo
Share this page

Gentium S.p.A (GENT)

(NasdaqGM: GENT)


GENTIUM S.P.A. INVESTOR ALERT: Faruqi & Faruqi, LLP Notifies Investors of Lead Plaintiff Deadline in Class Action Against Gentium S.p.A. (GENT)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, announces that a class action lawsuit against the Board of Directors of Gentium S.p.A. (“Gentium” or the “Company”) (NasdaqGM: GENT) for breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Jazz Pharmaceuticals has been filed in the United States District Court for the Southern District of New York. The case was filed on behalf of holders of Gentium American Depositary Shares (“ADSs”) on January 15, 2014. Investors have until March 17, 2014 to file lead plaintiff applications.

The complaint alleges that Gentium’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction and by filing a materially false and misleading Schedule 14D9 with the Securities and Exchange Commission in an attempt to gain shareholder support for the transaction. 

If you own common stock in Gentium and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Gentium S.p.A (GENT)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Juan E. Monteverde
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 01/17/2014

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.